MBX Biosciences (MBX) Current Leases (2023 - 2026)

MBX Biosciences has disclosed Current Leases across 4 years of filings, most recently posting $178000.0 for Q1 2026.

• Current Leases for Q1 2026 came in at $178000.0, up 36.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $178000.0 (up 36.92% YoY), and the FY2025 annual result was $172000.0, up 0.58% from the prior year.
• Current Leases came in at $178000.0 for Q1 2026 at MBX Biosciences, up from $172000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $178000.0 in Q1 2026 to a low of $130000.0 in Q1 2025.
• The 4-year median for Current Leases is $160000.0 (2024), against an average of $157750.0.
• Across the five-year window, Current Leases dropped 7.23% in 2025 and jumped 36.92% in 2026, its largest moves.
• MBX Biosciences' Current Leases stood at $153000.0 in 2023, then advanced by 11.76% to $171000.0 in 2024, then advanced by 0.58% to $172000.0 in 2025, then climbed by 3.49% to $178000.0 in 2026.
• The last three Current Leases figures came in at $178000.0 (Q1 2026), $172000.0 (Q4 2025), and $154000.0 (Q3 2025), per Business Quant data.